Market closed
Chemed/$CHE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Chemed
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
Ticker
$CHE
Sector
Trading on
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
15,695
Website
Chemed Metrics
BasicAdvanced
$8.4B
27.95
$20.53
0.49
$1.90
0.35%
Price and volume
Market cap
$8.4B
Beta
0.49
52-week high
$623.61
52-week low
$512.12
Average daily volume
145K
Dividend rate
$1.90
Financial strength
Current ratio
1.729
Quick ratio
1.582
Long term debt to equity
8.638
Total debt to equity
12.275
Dividend payout ratio (TTM)
9.19%
Interest coverage (TTM)
234.38%
Management effectiveness
Return on assets (TTM)
14.28%
Return on equity (TTM)
26.11%
Valuation
Price to earnings (TTM)
27.951
Price to revenue (TTM)
3.434
Price to book
7.1
Price to tangible book (TTM)
19.74
Price to free cash flow (TTM)
27.134
Dividend yield (TTM)
0.33%
Forward dividend yield
0.35%
Growth
Revenue change (TTM)
8.52%
Earnings per share change (TTM)
10.48%
3-year revenue growth (CAGR)
5.12%
3-year earnings per share growth (CAGR)
6.34%
3-year dividend per share growth (CAGR)
10.19%
What the Analysts think about Chemed
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Chemed stock.
Chemed Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Chemed Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Chemed News
AllArticlesVideos
Chemed Corporation (CHE) Q1 2025 Earnings Call Transcript
Seeking Alpha·1 week ago
Chemed To Report First-Quarter 2025 Earnings April 23, Related Conference Call To Be Held On April 24
Business Wire·1 month ago
Chemed Corporation to Present at the Oppenheimer 35th Annual Healthcare Conference
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Chemed stock?
Chemed (CHE) has a market cap of $8.4B as of May 03, 2025.
What is the P/E ratio for Chemed stock?
The price to earnings (P/E) ratio for Chemed (CHE) stock is 27.95 as of May 03, 2025.
Does Chemed stock pay dividends?
Yes, the Chemed (CHE) stock pays dividends to shareholders. As of May 03, 2025, the dividend rate is $1.9 and the yield is 0.35%. Chemed has a payout ratio of 9.19% on a trailing twelve-month basis.
When is the next Chemed dividend payment date?
The next Chemed (CHE) dividend payment date is unconfirmed.
What is the beta indicator for Chemed?
Chemed (CHE) has a beta rating of 0.49. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.